Could looser jaundice rules spare preterm babies unnecessary treatment?

NCT ID NCT07674537

First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time

Summary

This trial tests whether using higher (less strict) bilirubin thresholds for starting light therapy in very preterm infants (born before 30 weeks) is as safe as the current Dutch guidelines. About 680 babies across Dutch NICUs will be randomly assigned to one of two threshold strategies. The main goal is to see if the higher thresholds lead to similar rates of survival without developmental problems at age two, while reducing the burden of treatment and monitoring.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Phototherapy and exchange transfusion thresholds
What this could lead to
If higher thresholds are safe, fewer preterm infants may need intensive light therapy, reducing stress and parent-infant separation.
What could go wrong
This is a non-inferiority trial, so it may only show that the higher thresholds are not worse—not that they are better. Results may not apply outside the Netherlands.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EXCHANGE TRANSFUSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hyperbilirubinemia Hyperbilirubinemia, Neonatal Jaundice, Neonatal transient familial neonatal hyperbilirubinemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Beatrix Children's Hospital, University Medical Center Groningen

    Groningen, Provincie Groningen, 9713GZ, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.